Published Date:2021-02-09 Original Link:https://www.onenessbio.com/en/news_detail26_4.htm No 1 Date of announcement  2021/02/09 Time of announcement  17:10:57 Subject Oneness will not proceed with the ON101 Phase3 clinical trial (ON101CLCT04) application with BfArM of Germany based on strategic consideration.      To which item it meets paragraph 10 Date of events 2021/02/09 Statement 1.Product:ON101 2.Mass production date:NA 3.Effect on...Read More